Last reviewed · How we verify
KeraStat® Gel with Morphine application — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
KeraStat® Gel with Morphine application (KeraStat® Gel with Morphine application) — The Metis Foundation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| KeraStat® Gel with Morphine application TARGET | KeraStat® Gel with Morphine application | The Metis Foundation | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- KeraStat® Gel with Morphine application CI watch — RSS
- KeraStat® Gel with Morphine application CI watch — Atom
- KeraStat® Gel with Morphine application CI watch — JSON
- KeraStat® Gel with Morphine application alone — RSS
Cite this brief
Drug Landscape (2026). KeraStat® Gel with Morphine application — Competitive Intelligence Brief. https://druglandscape.com/ci/kerastat-gel-with-morphine-application. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab